The 18th Annual Drug Discovery Chemistry meeting will be held on April 10-13, 2023 in San Diego, CA, US and also online.
Early bird registration closes on December 16.
Drug Discovery Chemistry is a conference for medicinal and biophysical chemists working in pharma, biotech, and academia. The event is focused on discovery and optimisation challenges of small molecule drug candidates, with various content tracks running concurrently across the three days.
New for this year, the conference will cover targeting transcription factors. The organisers have also expanded the coverage of protein degraders, molecular glues, and artificial intelligence for early drug discovery.
Speakers from industry will include: AbbVie, Amgen, Astex Pharmaceuticals, AstraZeneca, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, GlaxoSmithKline, Janssen, Johnson & Johnson, Merck, Novartis, and Pfizer.
Interactive dinner short courses are also available, taught by leading researchers from industry and academia.
For more information, visit the Drug Discovery Chemistry website.
